NCT00294788View on ClinicalTrials.gov

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

January 31, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

Fluvax

DRUG

PCC® (Lactobacillus fermentum VRI 003)

Trial Locations (1)

2000

Good Health Solutions, Sydney

Sponsors

Lead Sponsor

Probiomics Ltd
All Listed Sponsors
lead

Probiomics Ltd

INDUSTRY